Introduction
Cryptococcus neoformans is an opportunistic infection that causes substantial morbidity and mortality in immunocompromised hosts, and can affect most organ systems. With the introduction of highly active anti-retroviral therapy in the 1980s, the incidence of cryptococcosis among human immunodeficiency virus (HIV)-infected persons has dramatically decreased. 1 Reports of pregnancyassociated cryptococcosis in the absence of other underlying risk factors, suggest that alterations in immune function during pregnancy contribute to an enhanced susceptibility to cryptococcal disease. 2 Despite the well-described occurrence of disease during pregnancy, documented congenital cryptococcosis is rare. We report a case of probable in utero transmission of C. neoformans from a 19-year-old woman with congenital HIV to her preterm infant. Placental pathology was diagnostic of C. neoformans infection, and we were able to document the presence of C. neoformans antigen in the neonatal serum.
Case
Patient PD was a 1080 g male delivered at 28 weeks estimated gestational age by cesarean section. His mother, AD, was a 19-yearold primigravid woman with perinatally acquired HIV-1 infection and a history of non-adherence to medical therapy. She presented to our hospital at 25 weeks gestation with a 1-week history of fever, cough and shortness of breath, and was admitted with a presumptive diagnosis of Pneumocystis jiroveci pneumonia. Admission CD4 þ T-cell count and HIV viral load (VL) were 20 cells per ml and 635 copies per ml, respectively. Her initial blood culture yielded C. neoformans and her serum cryptococcal antigen titer was 1:4096. A lumbar puncture revealed a cerebrospinal fluid cryptococcal antigen titer of 1:218 and was otherwise negative. Intravenous amphotericin B therapy was initiated; 5-fluorocytosine was deferred due to maternal pancytopenia and concern for fetal toxicity. AD's pulmonary status improved, but she remained nonadhererent to highly active anti-retroviral therapy despite directly observed in-patient anti-retroviral (ARV) treatment. HIV genotype/ phenotype testing confirmed susceptibility to her current ARVs. By 28 weeks gestation, the VL increased to 72 319 copies per ml, and she developed severe preeclampsia. Subcutaneous emfuvirtide and intravenous zidovudine were added to her regimen to prevent perinatal HIV transmission.
The infant, PD, was delivered by cesarean section and intubated in the delivery room for respiratory distress and bradycardia. His examination was consistent with an estimated gestational age of 28 weeks. Complete blood count showed a total white blood cell count of 6300 cells per ml with 14% neutrophils, 2% bands, 71% lymphocytes and 9% monocytes; hemoglobin of 12.6 g dl À1 ; and a platelet count of 217 000 platelets per ml. His chest radiograph demonstrated bilateral lung disease. He received empiric therapy with ampicillin and gentamicin.
The infant's serum cryptococcal antigen titer was positive (1:2) on the first day of life, and antifungal therapy was initiated with amphotericin B lipid complex. Evaluation of cerebrospinal fluid on the second day of life revealed white blood cell count of 2 cells per ml and red blood cell count of 50 cells per ml, a negative gram stain and culture, and a non-reactive cerebrospinal fluid cryptococcal antigen. Therapy was changed to fluconazole. Cryptococcal antigen testing of the bronchoalveolar fluid was negative. Repeat cryptococcal antigen titer was 1:2 at the fifth day of life, but was subsequently negative.
Owing to his mother's VL at delivery and extensive history of ARV exposure, PD was started on triple ARV therapy with intravenous zidovudine, oral lamivudine and oral lopinavir/ ritonavir on the first day of life. The infant's HIV-1 DNA PCR and RNA VL tests were non-detectable at 48 h of life.
Histological examination of the placenta revealed abundant mucin-positive, round budding fungal organisms within the maternal intervillous space with focal invasion into the chorionic villi ( Figure 1a ). Lesions were not associated with significant inflammation, and granulomas were not identified. Extensive organism-associated polysaccharide and shed polysaccharide within the intervillous space were demonstrated by immunohistochemical staining (Figures 1b and c) . These studies were done as described using a murine monoclonal antibody (18B7) that recognized the polysaccharide component of all cryptococcal serotypes as described. 3 Factor VIII staining confirmed the localization of C. neoformans within the villi (Figure 1c) . PD received HIV prophylaxis with three ARVs for 6 weeks, and cryptococcosis therapy with fluconazole for 3 months. He was discharged to a pediatric rehabilitation facility at 3 months of age, after a prolonged hospital stay secondary to complications of prematurity. All HIV DNA PCR tests were non-detectable. HIV antibody enzyme-linked immunosorbent assay result was negative by 18 months of age.
AD continued to have elevated cryptococcal titers and developed cardiomyopathy 4 months postpartum, which improved with supportive management. Although virological control remained suboptimal, her cryptococcal disease did not relapse. At 12 months postpartum, she was admitted for diarrhea and dehydration (CD4 þ T-cell count 3 cells per ml, HIV VL 31 534 copies per ml).
She expired from Staphylococcus aureus sepsis within 1 week of hospitalization.
Discussion
We consider this a probable case of congenital cryptococcosis that occurred as a result of transplacental transmission. Over a dozen cases of cryptococcosis in early infancy (for example, within the first 3 months of life) have been reported with a mortality greater than 50% (reviewed in Nakwan et al. 4 ; Sirinavin et al. Table) . Disease is typically a multisystemic disease, typically with involvement of the central nervous and respiratory systems. Early (for example, within hours to days of life) 6 and late presentations of cryptococcosis (weeks to months) 7 have been described in neonates. Both the forms of disease are generally presumed to represent congenital infection based on the lack of environmental exposure in the neonate and the presence of maternal cryptococcosis. Although it is possible that the presence of low-level antigenemia in our patient represented only transmission of polysaccharide antigen, we chose to treat this infant based on: (1) the presence of chorionic invasion, (2) the high morbidity of congenital cryptococcosis (see Supplementary Material Table) and (3) the presence of respiratory distress in our patient together with the nonspecific symptoms of congenital cryptococcosis. We note that the extremely large size of the cryptococcal polysaccharide (B10 6 Da) makes passive transfer of this molecule very unlikely. 8 The mechanisms leading to vertical transmission of cryptococcosis are unknown, but aspiration or swallowing of infected material during birth likely accounts for late forms of neonatal disease. This hypothesis is supported by case reports describing the isolation of C. neoformans from the genitourinary tract of pregnant and non-pregnant women. Endocervical fluid contamination with C. neoformans has been reported in a case of presumed congenital cryptococcosis. 9 Furthermore, C. neoformans has been isolated from the vaginal discharge 10 and endometrium 11 of animals that delivered infected offspring. Endometrial Neonatal cryptococcosis M Patel et al cryptococcosis has been reported in a 34-year-old female with AIDS who presented with severe menorrhagia, 12 and as a cause of tuboovarian abscess 13 and vaginal infection. 14 The placenta is an extremely effective barrier to fungal infection, and transplacental transmission of fungal infections, though reported, is rare. Several lines of evidence suggest that placental transmission of C. neoformans infection, although rare, can occur. This includes: (1) the early presentation of cryptococcosis in neonates (within hours of birth) 15, (2) the association with intracranial calcifications in some cases 9 and (3) histopathological evidence (including our own) of chorionic villi invasion. Darko et al. 16 reviewed three cases of placental cryptococcosis. In two cases, infection was limited to the intervillous space without extension, but in the third case extension into the chorionic villi was present. None of the neonates in this series demonstrated evidence of infection. Recently, Rahimi et al. 17 described cryptococcemia that resulted in an incomplete abortion in an HIV-positive patient. Histological examination of the dilation and curettage specimen revealed chorionic villi invasion without endometrial disease. Taken together, these studies highlight the importance of placental examination in the evaluation of neonates born to mothers with active cryptococcosis.
) (Supplementary Material
Our report also underscores the complexities of managing opportunistic infections in HIV-1-infected pregnant women. We hypothesize that the profound immunodeficiency associated with AIDS in our case likely contributed to placental transfer of the organism. Although reports of pregnancy outcomes among congenital HIV-1-infected women with adequate prenatal care are limited, reported rates of HIV vertical transmission remain low (0 to 3.3%) and are comparable to those of non-congenitally infected women. However, congenitally infected women may experience higher risks of morbidity with pregnancy. 18 A recent comparison of pregnant young women with congenitally or horizontally acquired HIV suggested that congenitally infected women were less likely to achieve viral suppression during pregnancy, had lower CD4 þ T-cell counts during pregnancy, delivered babies of lower birth weight and were more likely to remain viremic with low CD4 þ T-cell counts at 1 month and 1 year postpartum. 19 The mother described in this report never achieved virological control or CD4 þ T-cell reconstitution and died 12 months postpartum.
